Serum-Free Stem Cell Differentiation via BMP4 and VEGF
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing mesoderm and hematopoietic stem cells or progenitor cells from pluripotent stem cells often involve forming embryoid bodies or coculturing with different species, which are inefficient and introduce uncertainties, and there is a lack of methods using a restricted number of culture medium components.
Innovation Solution
Culturing pluripotent stem cells in a serum-free medium supplemented with BMP4 and VEGF, followed by the addition of hematopoietic factors, to induce differentiation into mesodermal cells and subsequently hematopoietic stem cells or progenitor cells without forming embryoid bodies or coculturing, using specific cytokines and growth factors like SCF, Wnt3a, and Matrigel-coated dishes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If embryoid body formation method is used, then blood cells can be differentiated from pluripotent stem cells, but only a part of the cells are differentiated into blood cells while many other cells are induced to differentiate into other types of cells
Solution Approach 1:
The differentiation process is divided into distinct stages: first forming mesodermal cells using BMP4 and VEGF, then subsequently differentiating these mesodermal cells into hematopoietic stem cells or progenitor cells using hematopoietic factors. This segmentation allows for controlled differentiation at each stage, improving both efficiency and purity of the final blood cell product.
Solution Approach 2:
The invention introduces a preliminary step of differentiating pluripotent stem cells into mesodermal cells before proceeding to hematopoietic differentiation. This preliminary action creates a more committed cell population that is primed for blood cell differentiation, thereby increasing the proportion of cells that will successfully become blood cells and reducing differentiation into unrelated cell types.
2Productivity
If coculture with stromal cells derived from a different species is used, then blood cells can be prepared from pluripotent stem cells, but the culture medium has many components which introduces uncertainties
Solution Approach 1:
The invention extracts and eliminates the coculture step with stromal cells from different species, achieving blood cell differentiation using only human pluripotent stem cells in a defined culture medium. This removal of extraneous elements reduces variability and improves reliability of the differentiation model.
Solution Approach 2:
The invention changes the culture parameters from an undefined coculture system to a defined medium containing specific cytokines and growth factors (BMP4, VEGF, and hematopoietic factors) at controlled concentrations. This parameter standardization ensures consistent and reproducible differentiation results across experiments.
3Ease of operation
If a culture medium with many components is used, then cell differentiation can proceed, but uncertainties increase
Solution Approach 1:
The invention transitions from using complex, undefined culture media to a defined medium with specified concentrations of essential cytokines and growth factors. This parameter definition maintains differentiation capability while eliminating the variability introduced by undefined medium components, thereby improving experimental consistency.
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
The present invention provides a method for inducing differentiation of pluripotent stem cells into mesodermal cells, comprising the step of culturing pluripotent stem cells in a serum-free medium without forming an embryoid body and without coculturing with cells from a different species.